genedrive (LON:GDR) Trading Down 9.2% – Should You Sell?

genedrive plc (LON:GDR)’s stock price traded down 9.2% on Monday . The stock traded as low as GBX 0.77 and last traded at GBX 0.77. 546,245 shares were traded during mid-day trading, a decline of 97% from the average session volume of 19,084,951 shares. The stock had previously closed at GBX 0.85.

genedrive Stock Down 9.2%

The company has a debt-to-equity ratio of 0.35, a current ratio of 4.60 and a quick ratio of 5.52. The company has a market cap of £7.95 million, a PE ratio of -0.36 and a beta of -0.04. The business’s 50 day moving average is GBX 0.86 and its 200-day moving average is GBX 0.89.

genedrive Company Profile

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.